SEC Form D · filed November 29, 2021
Kala Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Kim Brazzell · Watertown, MAExecAndrew L. Koven · Watertown, MADirectorHoward B. Rosen · Watertown, MADirectorGregory D. Grunberg · Watertown, MADirectorMark Iwicki · South San Francisco, CAExec · DirectorHongming Chen · Watertown, MAExecRobert D. Paull · Watertown, MADirectorC. D. Myers · Alpharetta, GADirectorTodd Bazemore · Watertown, MAExecGregory D. Perry · Cambridge, MADirectorMary Reumuth · Watertown, MAExecMark S. Blumenkranz · San Francisco, CADirectorDarius D. Kharabi · Watertown, MAExecEric L. Trachtenberg · MONTREAL, Quebec, CanadaExecKim Brazzell · Watertown, MAExecGregory D. Perry · Cambridge, MADirectorMary Reumuth · Watertown, MAExecMark S. Blumenkranz · Watertown, MADirectorAndrew L. Koven · Watertown, MADirectorDarius D. Kharabi · Watertown, MAExecHoward B. Rosen · Redwood City, CADirectorGregory D. Grunberg · Watertown, MADirectorMark Iwicki · CHELSEA, MAExec · DirectorHongming Chen · Waltham, MAExecRobert D. Paull · Watertown, MADirectorEric L. Trachtenberg · Vancouver, British Columbia, CanadaExecC. D. Myers · Alpharetta, GADirectorTodd Bazemore · Watertown, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗